Entourage Health Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, sales was CAD 42.39 million compared to CAD 41.69 million a year ago. Revenue was CAD 32.19 million compared to CAD 31.67 million a year ago. Net loss was CAD 35.22 million compared to CAD 34.43 million a year ago. Basic loss per share from continuing operations was CAD 0.12 compared to CAD 0.15 a year ago. Diluted loss per share from continuing operations was CAD 0.12 compared to CAD 0.15 a year ago.